Herbalife India Releases New Episode of 'Live Your Best Life, Unscripted' Podcast
Herbalife India has launched a new episode of its flagship podcast featuring Dr. Aditi Govitrikar to discuss healthy ageing, metabolism, and holistic well-being.
Stocks · News reference
Argus Research analyst John Staszak has reiterated a 'Buy' rating on Herbalife (NYSE: HLF) and increased the price target from $15 to $20.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Herbalife India has launched a new episode of its flagship podcast featuring Dr. Aditi Govitrikar to discuss healthy ageing, metabolism, and holistic well-being.
High Liner Foods has received an interim court order from the Supreme Court of Nova Scotia and scheduled a special meeting of shareholders for December 15, 2026, to vote on its proposed acquisition by Umios.
High Liner Foods Incorporated announced that it has received an interim order from the Supreme Court in connection with its ongoing corporate proceedings.
Argus Research has reaffirmed its "Buy" rating for Herbalife shares.
High Liner Foods Incorporated announced its financial results for the thirteen and thirty-nine weeks ended October 3, 2026, reporting growth in sales, net income, and Adjusted EBITDA.
Herbalife India has partnered with the Indian Institute of Science (IISc) to launch a multi-centric research study focused on metabolic health and healthy aging.